These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. [Anti-NR1 antibodies in anti-N-methyl-D-aspartate receptor encephalitis and schizophrenia]. Le Guen E; Doukhan R; Hamdani N; Tamouza R; Groc L; Honnorat J; Leboyer M Med Sci (Paris); 2015 Jan; 31(1):60-7. PubMed ID: 25658732 [TBL] [Abstract][Full Text] [Related]
48. Anti-NMDA receptor encephalitis with atypical brain changes on MRI. Chan SH; Wong VC; Fung CW; Dale RC; Vincent A Pediatr Neurol; 2010 Oct; 43(4):274-8. PubMed ID: 20837307 [TBL] [Abstract][Full Text] [Related]
49. Anti-N-methyl-D-aspartate receptor encephalitis associated with hepatic neuroendocrine carcinoma: A case report. Lim EW; Yip CW J Clin Neurosci; 2017 Jul; 41():70-72. PubMed ID: 28262407 [TBL] [Abstract][Full Text] [Related]
50. Epileptogenic effects of NMDAR antibodies in a passive transfer mouse model. Wright S; Hashemi K; Stasiak L; Bartram J; Lang B; Vincent A; Upton AL Brain; 2015 Nov; 138(Pt 11):3159-67. PubMed ID: 26373601 [TBL] [Abstract][Full Text] [Related]
51. Case 27-2018: A 3-Year-Old Boy with Seizures. Gorman MP; Gombolay GY; Mehan WA; Thibert RL N Engl J Med; 2018 Aug; 379(9):870-878. PubMed ID: 30157393 [No Abstract] [Full Text] [Related]
52. A case of anti-N-methyl-D-aspartate receptor encephalitis with systemic sclerosis. Suzuki H; Samukawa M; Kitada M; Ichihashi J; Mistui Y; Tanaka K; Kusunoki S Eur J Neurol; 2011 Nov; 18(11):e145-6. PubMed ID: 21985028 [No Abstract] [Full Text] [Related]
53. [Diagnosis and differential diagnosis of anti-N-methyl-D-aspartate receptor encephalitis in children]. Wang H Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jun; 16(6):578-83. PubMed ID: 24927431 [TBL] [Abstract][Full Text] [Related]
54. [Acute encephalitis anti-ionotropic glutamate receptor activated N-methyl-D-aspartate (NMDAR): analysis of eleven pediatric cases in Argentina (Benito Yelín Award)]. Pérez E; Ruggieri V; Monges S; Loos M; Caraballo R; Yerga A; Rugilo C; Vincent A; Arroyo HA Medicina (B Aires); 2013; 73 Suppl 1():1-9. PubMed ID: 24072045 [TBL] [Abstract][Full Text] [Related]
55. Detection of NMDARs Antibodies in Encephalitis. Gastaldi M; Waters P; Vincent A Methods Mol Biol; 2017; 1677():117-126. PubMed ID: 28986868 [TBL] [Abstract][Full Text] [Related]
56. MRI Findings Suggestive of Herpes Simplex Encephalitis in Patients with Anti-NMDA Receptor Encephalitis. Scheel M; Finke C AJNR Am J Neuroradiol; 2018 Nov; 39(11):E120. PubMed ID: 30213819 [No Abstract] [Full Text] [Related]
57. Psychiatric Autoimmunity: N-Methyl-D-Aspartate Receptor IgG and Beyond. Kruse JL; Lapid MI; Lennon VA; Klein CJ; Toole OO; Pittock SJ; Strand EA; Frye MA; McKeon A Psychosomatics; 2015; 56(3):227-41. PubMed ID: 25975857 [TBL] [Abstract][Full Text] [Related]
58. Anti-NMDAR encephalitis following herpes simplex encephalitis: A case report and update on diagnostic and treatment. Haddad A; Rambaud T; Tran Ba S; Manceau P; Degos B; Mongin M Rev Neurol (Paris); 2022 Dec; 178(10):1107-1109. PubMed ID: 36369066 [No Abstract] [Full Text] [Related]
59. Anti-N-methyl-D-aspartate receptor encephalitis: a common cause of encephalitis in the intensive care unit. Chen X; Li JM; Liu F; Wang Q; Zhou D; Lai X Neurol Sci; 2016 Dec; 37(12):1993-1998. PubMed ID: 27620725 [TBL] [Abstract][Full Text] [Related]
60. Autoimmune encephalitis and its relation to infection. Venkatesan A; Benavides DR Curr Neurol Neurosci Rep; 2015 Mar; 15(3):3. PubMed ID: 25637289 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]